Entero Therapeutics, Inc. (GRDX) — Financial Flexibility Index

Latest as of September 2025: -0.02x

Entero Therapeutics, Inc. (GRDX) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-855.69K (operating CF $-855.69K minus capex $0.00) represents 0% of total liabilities ($45.81 Million). Also explore how fast is Entero Therapeutics, Inc. growing its equity to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.02x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-855.69K
Operating CF − Capex

Total Liabilities

$45.81 Million
USD

Capital Expenditures

$0.00
USD

Entero Therapeutics, Inc. Financial Flexibility Index (2013–2024)

Historical Financial Flexibility Index trend for Entero Therapeutics, Inc. across 12 annual periods. Check GRDX financial resilience to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Entero Therapeutics, Inc. (2013–2024)

Year-by-year free cash flow to debt coverage for Entero Therapeutics, Inc.. For the full company profile including market capitalisation, see GRDX market cap overview.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -0.33x $-9.22 Million $-9.22 Million $27.61 Million ▲ +90.8%
2023 -3.62x $-11.88 Million $-12.38 Million $3.28 Million ▲ +56.3%
2022 -8.28x $-22.34 Million $-22.34 Million $2.70 Million ▼ -639.4%
2021 -1.12x $-21.97 Million $-32.29 Million $19.61 Million ▼ -55.4%
2020 -0.72x $-11.22 Million $-11.22 Million $15.56 Million ▲ +78.0%
2019 -3.27x $-14.01 Million $-14.03 Million $4.29 Million ▲ +7.3%
2018 -3.53x $-10.56 Million $-10.87 Million $3.00 Million ▼ -88.3%
2017 -1.87x $-7.15 Million $-7.18 Million $3.82 Million ▼ -46.6%
2016 -1.28x $-4.52 Million $-4.53 Million $3.54 Million ▼ -217.8%
2015 -0.40x $-4.15 Million $-4.17 Million $10.32 Million ▼ -57.1%
2014 -0.26x $-1.01 Million $-1.01 Million $3.93 Million ▼ -425109.5%
2013 0.00x $56.55 $56.55 $939.30K —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities